The Portfolio
-
AcuFocus, Inc.
AcuFocus has developed an innovative corneal implant technology to treat presbyopia. AcuFocus was founded within The Innovation Factory in 2001.
Coinvestors include Versant Ventures, The Carlyle Group, SV Life Sciences, Pequot Ventures, Bausch & Lomb, Medtronic Inc. and Cowen Healthcare Royalty Partners.
-
AqueSys
AqueSys is developing a novel implant to lower intraocular pressure in glaucoma patients. AqueSys was founded within The Innovation Factory.
Coinvestors include SV Life Sciences and The Carlyle Group .
-
AxoGen
AxoGen provides surgeons a novel solution to repair and regenerate peripheral nerves.
Axogen is now a public company trading under the ticker symbol AXGN.
-
CardioFocus
CardioFocus is developing a catheter-based approach to treating atrial fibrillation.
Coinvestors include Oxford Biosciences, SV Life Sciences, H.I.G. Ventures, Aurora Funds and KBL Healthcare Ventures.
-
Halscion
Halscion is developing a novel technology to treat a common dermatological condition. Halscion was founded in 2008 and operates within The Innovation Factory.
Coinvestors include Versant Ventures and SV Life Sciences.
-
Inogen, Inc.
Inogen has commercialized low-weight, portable oxygen concentrators to serve as full-time replacement devices for the home oxygen market.
Coinvestors include Versant Ventures, Novo Ventures, Arboretum Ventures and Avalon Ventures.
-
Intuity Medical
Intuity Medical is developing a novel fully integrated blood glucose monitor for the diabetes market.
Coinvestors include Versant Ventures, USVP, Venrock, IGC and Thomas McNerney.
-
LipoSonix, Inc.
LipoSonix focuses on providing a non-invasive alternative to liposuction surgery using High Intensity Focused Ultrasound (HIFU) technology. LipoSonix was founded within The Innovation Factory in 2001 and was acquired by Medicis Pharmaceutical Corporation in 2008.
Coinvestors include Three Arch Partners, Versant Ventures, Delphi Ventures, The Carlyle Group, Essex Woodlands Health Ventures, Pinnacle Ventures and SV Life Sciences.
-
MyoScience
MyoScience is developing novel technologies for aesthetic medicine.
Coinvestors include De Novo Ventures, Nexus Medical and Saratoga Ventures.
-
NeoVista, Inc.
NeoVista is developing a therapy for the wet form of age related macular degeneration (AMD). NeoVista was founded within The Innovation Factory.
Coinvestors include Versant Ventures, The Carlyle Group, Essex Woodlands Health Ventures, SV Life Sciences and MPM Capital.
-
Neuronetics, Inc.
Neuronetics has developed a Transcranial Magnetic Stimulation (TMS) system to treat depression. Neuronetics was founded within The Innovation Factory.
Coinvestors include New Leaf Partners, Three Arch Partners, InterWest Partners, ONSET Ventures, Quaker Bioventures, KBL Healthcare Ventures, Investor AB, Polaris Ventures and Pfizer Ventures.
-
Nevro
Nevro is a medical device company developing an implantable device for the treatment of chronic pain.
Coinvestors include Aberdare Ventures, Bay City Capital, Three Arch Partners, MPM Capital, Mayo Medical Ventures and Johnson & Johnson Development Corporation.
-
Respicardia
Respicardia is developing a neurostimulation technology to treat Congestive Heart Failure patients with Central Sleep Apnea.
Coinvestors include Versant Ventures, Three Arch Partners, Polaris Ventures, Affinity Capital and RKV Ventures Group.
-
Sadra Medical
Sadra Medical is developing minimally invasive alternatives to surgical aortic valve replacement.
Sadra Medical was acquired in Q1 2011 by Boston Scientific (NYSE: BSX) for $193M with additional contingent payments of up to $193M.
-
Sebacia
Sebacia is developing novel technology to address a large unmet need in dermatology. The company was founded in 2010 and is currently operating within The Innovation Factory.
Coinvestors include Versant Ventures, Domain Associates and the Partners Healthcare Innovation Fund.
-
SoftScope
Softscope is developing a disposable accessory for use with existing colonoscopes that will make colonoscopy more comfortable for patients, easier and faster for physicians and potentially eliminate the need for I.V. sedation.
SoftScope was acquired in October 2010 by Fujinon.
-
Torax Medical
Torax Medical is developing the LINX™ Reflux Management System for the treatment of GERD.
Coinvestors include Thomas, McNerney and Partners, Sanderling Ventures, Mayo Medical Ventures, and Kaiser Permanente.
-
WaveTec Vision
WaveTec Vision is developing ORange™, a novel wavefront measurement technology that provides on-demand, intraoperative information to cataract and refractive surgeons.
Coinvestors include Versant Ventures and De Novo Ventures.
